During the corresponding time, Sonoma Pharmaceuticals Inc recorded a revenue increase by 59.55 % year on year, sequentially revenue grew by 15.2 %. While revenue at the Sonoma Pharmaceuticals Inc 's corporate clients
Sonoma Pharmaceuticals Inc's Comment on Sales, Marketing and Customers
The company serves a diverse customer base across consumer markets, hospital systems, home healthcare, and other healthcare channels primarily in the United States and in over 55 countries internationally. Its U.S. retail customers include CVS and Walmart stores, which carry the company's HOCl-based burn relief hydrogel and diaper rash products. Persōn & Covey, Inc. distributes the company's Aquanil® AD dermatology products through over-the-counter dermatology channels in the U.S. Medline Industries, LP distributes the company's HOCl wound cleanser to hospital systems and healthcare channels in the U.S. Additionally, a U.S.-based distributor sells Microcyn technology-based products to large U.S. retailers. In the U.K., a leading health and beauty retailer and pharmacy chain markets the company's hypochlorous acid-based acne products. The company has also obtained regulatory approval for wound care products in Ukraine. Its dermatology product focus includes pain and itch relief from skin irritations, scar management, and other dermatologic conditions. The company positions itself as a developer and producer of stabilized hypochlorous acid (HOCl) solutions, drawing on over 20 years of scientific knowledge and manufacturing experience.
Sonoma Pharmaceuticals Inc’s Comment on Sales, Marketing and Customers
The company serves a diverse customer base across consumer markets, hospital systems, home healthcare, and other healthcare channels primarily in the United States and in over 55 countries internationally. Its U.S. retail customers include CVS and Walmart stores, which carry the company's HOCl-based burn relief hydrogel and diaper rash products. Persōn & Covey, Inc. distributes the company's Aquanil® AD dermatology products through over-the-counter dermatology channels in the U.S. Medline Industries, LP distributes the company's HOCl wound cleanser to hospital systems and healthcare channels in the U.S. Additionally, a U.S.-based distributor sells Microcyn technology-based products to large U.S. retailers. In the U.K., a leading health and beauty retailer and pharmacy chain markets the company's hypochlorous acid-based acne products. The company has also obtained regulatory approval for wound care products in Ukraine. Its dermatology product focus includes pain and itch relief from skin irritations, scar management, and other dermatologic conditions. The company positions itself as a developer and producer of stabilized hypochlorous acid (HOCl) solutions, drawing on over 20 years of scientific knowledge and manufacturing experience.
Sources:
Sonoma Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Sonoma Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Sonoma Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
7.49 %